Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:32 PM
Ignite Modification Date:
2025-12-24 @ 10:32 PM
NCT ID:
NCT04929535
Eligibility Criteria:
Inclusion Criteria:
* Pathologically confirmed measurable basal cell carcinoma (BCC) or well to moderately differentiated squamous cell carcinoma (SCC)
* Age 18 years or older
* Able to provide informed consent
Exclusion Criteria:
* Lesion with indistinct borders
* Any evidence of metastatic disease
* Poor performance status (Eastern Cooperative Oncology Group \> 1) with life expectancy of less than 2 years
* Gorlins syndrome, a genetic predisposition to multiple skin cancers where surveillance and early intervention is of paramount importance
* Any recurrent cancer after surgery or radiation
* Very extensive carcinoma that cannot be readily removed by surgery or treated by radiation using orthovoltage or electron beam
* History of cutaneous photosensitization, porphyria or photodimerization as their tolerance to hydrogen peroxide application is unpredictable
* Previous application of 5-Fluorouracil cream to the lesion within the last 8 weeks
* Any immune-compromised patients where skin cancers can be very aggressive
* Patients who are unwilling to return for 1-year follow-up assessment
* Poorly differentiated SCC
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04929535
Study Brief:
Protocol Section:
NCT04929535